Access

News and Views


Nature Medicine 10, 1304 - 1305 (2004)
doi:10.1038/nm1204-1304

Antibody diversity: one enzyme to rule them all

Michel C Nussenzweig1 & Frederick W Alt2

  1. Michael C. Nussenzweig is in the Laboratory of Molecular Immunology and the Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021, USA. e-mail: nussen@mail.rockefeller.edu
  2. Frederick W. Alt is at the Howard Hughes Medical Institute, The Children's Hospital, and The Center for Blood Research and Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA. e-mail: alt@enders.tch.harvard.edu


Three reactions diversify antibody genes in human somatic cells of the B lineage: VDJ recombination, somatic hypermutation and class-switch recombination. The discovery of activation-induced cytidine deaminase (AID) has led to the elucidation of a unified molecular mechanism for initiation of the last two reactions and suggests why B cells undergoing these reactions are prone to cancer-associated DNA damage.


Hundreds of billions of different antibodies are produced to fight off invading pathogens. Two general classes of antigen receptor gene diversification processes in B lymphocytes account for this panopoly antigen-independent and antigen-dependent processes.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Class switching and Myc translocation: how does DNA break?

Nature Immunology News and Views (01 Nov 2004)

Mutations in AID and UNG extend the function of AID

Nature Immunology News and Views (01 Oct 2003)

See all 8 matches for News And Views